Cryo Cell International (CCEL) EBT Margin (2010 - 2026)

Cryo Cell International has disclosed EBT Margin across 17 years of filings, most recently posting 0.92% for Q1 2026.

• In Q1 2026, EBT Margin fell 578.0% year-over-year to 0.92%; the TTM figure through Feb 2026 stood at 8.95% (down 1688.0% YoY), while the FY2025 annual figure was 7.4%, down 1617.0% from the prior year.
• EBT Margin climbed to 0.92% in Q1 2026, from 59.06% in the prior quarter.
• Over the last five years, EBT Margin for CCEL reached as high as 18.3% in Q2 2024 and fell as low as 203.04% in Q4 2023.
• The 5-year median for EBT Margin is 8.34% (2022), against an average of 7.03%.
• Annual changes were most pronounced in 2023 — EBT Margin sank 21106 bps — and 2024, when it soared 19254 bps.
• A 5-year view of EBT Margin shows it stood at 8.02% in 2022, then slumped by 2632 bps to 203.04% in 2023, then surged by 95 bps to 10.5% in 2024, then slumped by 463 bps to 59.06% in 2025, then surged by 102 bps to 0.92% in 2026.
• According to Business Quant data, EBT Margin over the past three periods registered 0.92%, 59.06%, and 15.16% for Q1 2026, Q4 2025, and Q3 2025 respectively.